TRCT
VERA icon

Tower Research Capital (TRC)’s Vera Therapeutics VERA Stock Holding History

Tower Research Capital (TRC)’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Sell
3,427
-453
-12% -$16.9K ﹤0.01% 1918
2026
Q1 		$156K Buy
3,880
+3,343
+623% +$144K ﹤0.01% 1815
2025
Q4 		$27.2K Sell
537
-2,639
-83% -$93.7K ﹤0.01% 2871
2025
Q3 		$92.3K Sell
3,176
-1,010
-24% -$23.4K ﹤0.01% 2056
2025
Q2 		$98.6K Buy
4,186
+2,757
+193% +$62K ﹤0.01% 2386
2025
Q1 		$34.3K Sell
1,429
-9,046
-86% -$291K ﹤0.01% 2513
2024
Q4 		$443K Buy
10,475
+10,235
+4,265% +$453K 0.01% 1153
2024
Q3 		$10.6K Sell
240
-5,667
-96% -$215K ﹤0.01% 3738
2024
Q2 		$214K Buy
5,907
+5,443
+1,173% +$216K ﹤0.01% 2021
2024
Q1 		$20K Sell
464
-7,831
-94% -$279K ﹤0.01% 2999
2023
Q4 		$128K Buy
8,295
+5,956
+255% +$75.6K ﹤0.01% 2445
2023
Q3 		$32.1K Buy
2,339
+411
+21% +$7.05K ﹤0.01% 2968
2023
Q2 		$30.9K Sell
1,928
-2,906
-60% -$26.2K ﹤0.01% 2999
2023
Q1 		$38K Buy
4,834
+4,303
+810% +$33.2K ﹤0.01% 2764
2022
Q4 		$10K Sell
531
-1,004
-65% -$18.2K ﹤0.01% 4089
2022
Q3 		$33K Buy
1,535
+105
+7% +$1.97K ﹤0.01% 3532
2022
Q2 		$19K Buy
1,430
+1,203
+530% +$21K ﹤0.01% 3863
2022
Q1 		$5K Sell
227
-311
-58% -$6.69K ﹤0.01% 5111
2021
Q4 		$14K Sell
538
-67
-11% -$1.48K ﹤0.01% 4115
2021
Q3 		$10K Buy
+605
New +$10.8K ﹤0.01% 4343

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Tower Research Capital (TRC)'s VERA Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Vera Therapeutics (VERA) stake by 12% in Q2 2026, selling an estimated $16.9K and leaving 3,427 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #1918.

Tower Research Capital (TRC) first reported a position in VERA in Q3 2021 and has held it in 20 quarters since. The position peaked at $443K in Q4 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Tower Research Capital (TRC) held 3,427 shares of Vera Therapeutics worth $147K as of Q2 2026.
  • Tower Research Capital (TRC) sold 453 Vera Therapeutics shares in Q2 2026, an estimated $16.9K.
  • Vera Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1918 holding.
  • Tower Research Capital (TRC) first reported a position in Vera Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Vera Therapeutics position peaked at $443K in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.